Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...
Top vaccine official forced out of FDA
The head of the US Food and Drug Administration department responsible for assuring the safety and effectiveness of vaccines ...